{"version":"1.0","provider_name":"ANDERA PARTNERS","provider_url":"https:\/\/www.anderapartners.com\/fr\/","author_name":"Nicolas Delsert","author_url":"https:\/\/www.anderapartners.com\/fr\/author\/n-delsert\/","title":"BioDiscovery c\u00e8de Corvidia \u00e0 Novo Nordisk - ANDERA PARTNERS","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"PnwHDn3h3m\"><a href=\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-cede-corvidia-a-novo-nordisk\/\">BioDiscovery c\u00e8de Corvidia \u00e0 Novo Nordisk<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-cede-corvidia-a-novo-nordisk\/embed\/#?secret=PnwHDn3h3m\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0BioDiscovery c\u00e8de Corvidia \u00e0 Novo Nordisk\u00a0\u00bb &#8212; ANDERA PARTNERS\" data-secret=\"PnwHDn3h3m\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/06\/cordivia_logo.jpg","thumbnail_width":710,"thumbnail_height":262,"description":"PARIS, France \u2013 le 11 juin 2020 \u2013 BioDiscovery, investisseur europ\u00e9en de r\u00e9f\u00e9rence en capital-risque dans le domaine des Sciences de la Vie, g\u00e9r\u00e9 par Andera Partners, annonce la cession de Corvidia Therapeutics, une soci\u00e9t\u00e9 de biotechnologie am\u00e9ricaine sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de th\u00e9rapies cardiovasculaires, \u00e0 Novo Nordisk (NOVOB: Copenhagen). Le montant total de la..."}